Dechra Pharmaceuticals, a business involved in the development and marketing of veterinary products, saw its share price increase approximately 15% last week. This was after a cash offer made by Freya Bidco Limited for the entire issued, and to be issued, ordinary share capital of Dechra for 3,875p per share. This represented a 44% premium to the closing price of 2,690 pence on the 12th April, the last business day before the commencement of the Offer Period...

Stocks featured:

Dechra Pharmaceuticals, B&M and Greencore

To find out more about the investment management services offered by Walker Crips, please visit our website:

https://www.walkercrips.co.uk/

This podcast is intended to be Walker Crips Investment Management’s own commentary on markets. It is not investment research and should not be construed as an offer or solicitation to buy, sell or trade in any of the investments, sectors or asset classes mentioned. The value of any investment and the income arising from it is not guaranteed and can fall as well as rise, so that you may not get back the amount you originally invested. Past performance is not a reliable indicator of future results. Movements in exchange rates can have an adverse effect on the value, price or income of any non-sterling denominated investment. Nothing in this podcast constitutes advice to undertake a transaction, and if you require professional advice you should contact your financial adviser or your usual contact at Walker Crips. Walker Crips Investment Management Limited is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange.

Hosted on Acast. See acast.com/privacy for more information.